Home/Filings/4/0001192482-18-000015
4//SEC Filing

Graff Fred 4

Accession 0001192482-18-000015

CIK 0001588972other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:47 PM ET

Size

7.1 KB

Accession

0001192482-18-000015

Insider Transaction Report

Form 4
Period: 2018-01-02
Graff Fred
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2018-01-02+12,90022,900 total
  • Award

    Employee Stock Option (right to buy)

    2018-01-02+25,80025,800 total
    Exercise: $9.04Exp: 2028-01-02Common Stock (25,800 underlying)
Footnotes (2)
  • [F1]All shares of common stock are represented by unvested restricted stock units that will vest in four equal annual installments beginning January 2, 2019, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
  • [F2]The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.

Issuer

Recro Pharma, Inc.

CIK 0001588972

Entity typeother

Related Parties

1
  • filerCIK 0001667407

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:47 PM ET
Size
7.1 KB